Bifidobacterium Pseudolongum ‐Derived Acetate Attenuates Acute Pancreatitis Through GPR43‐Mediated Suppression of M1 Macrophage Polarization
Advanced Science · 2026
DOI: 10.1002/advs.202517642 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Langyi Guan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Diges…. Hauptthemen laut MEDLINE: Pancreatitis, Acetates, Macrophages, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Double-Thousand Plan of Jiangxi Province, Science and Technology Innovation Team Cultivation Project of the First Affiliated Hospital of Nanchang University.
Abstract (Originalsprache)
Acute pancreatitis (AP) is characterized by gut microbiota dysbiosis, which is marked by an expansion of pathogenic bacteria and a pronounced depletion of beneficial taxa, including Bifidobacterium . While Bifidobacterium pseudolongum ( B. pseudolongum ) possesses known probiotic properties, its potential role in protecting against AP has yet to be determined. This study shows that B. pseudolongum alleviates pancreatic damage, inflammation, and apoptosis in mice with caerulein‐induced and pancreatic duct ligation‐induced AP by enhancing gut barrier function and microbiota diversity. Metabolomics identifies acetate as its key metabolite, and the ackA gene is essential for acetate biosynthesis. Acetate supplementation protects against AP. Mechanistically, acetate acts via GPR43 to inhibit macrophage M1 polarization, and macrophage depletion abrogates this protection. Clinically, the fecal B. pseudolongum abundance is reduced in AP patients and is correlated with disease severity. These findings reveal a microbiota‐metabolite‐immune axis in AP and highlight the potential of B. pseudolongum and acetate supplementation as novel therapeutic strategies for AP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical…
- Postdoctoral Innovation Practice Base, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- Huankui Academy, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
ORCID-Profile: Yin Zhu
Förderung
- National Natural Science Foundation of China
- Double-Thousand Plan of Jiangxi Province
- Science and Technology Innovation Team Cultivation Project of the First Affiliated Hospital of Nanchang University
- Key Laboratory Project of Digestive Diseases in Jiangxi Province
- the Jiangxi Clinical Research Center for Gastroenterology
Zitieren
APA
Guan, L., Li, X., He, C., Zheng, P., Zou, Y., Zhu, Q., Li, X., Liang, J., Yang, J., Zhang, L., Ye, Y., Wan, J., Ke, H., Liu, J., Lu, N., Li, N., & Zhu, Y. (2026). Bifidobacterium Pseudolongum ‐Derived Acetate Attenuates Acute Pancreatitis Through GPR43‐Mediated Suppression of M1 Macrophage Polarization. Advanced Science. https://doi.org/10.1002/advs.202517642
Vancouver
Guan L, Li X, He C, Zheng P, Zou Y, Zhu Q, et al. Bifidobacterium Pseudolongum ‐Derived Acetate Attenuates Acute Pancreatitis Through GPR43‐Mediated Suppression of M1 Macrophage Polarization. Advanced Science. 2026. doi:10.1002/advs.202517642
BibTeX
@article{Guan2026,
author = {Guan, Langyi and Li, Xueyang and He, Cong and Zheng, Pan and Zou, Yaoyu and Zhu, Qi and Li, Xin and Liang, Jie and Yang, Junmin and Zhang, Li and Ye, Yuman and Wan, Jianhua and Ke, Huajing and Liu, Jianping and Lu, Nonghua and Li, Nianshuang and Zhu, Yin},
title = {Bifidobacterium Pseudolongum ‐Derived Acetate Attenuates Acute Pancreatitis Through GPR43‐Mediated Suppression of M1 Macrophage Polarization},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202517642}
}
EUVIMED